Xu SC - Search Results

1

FNDC5 alleviates oxidative stress and cardiomyocyte apoptosis in doxorubicin-induced cardiotoxicity via activating AKT.

Zhang X, Hu C, Kong CY, Song P, Wu HM, Xu SC, Yuan YP, Deng W, Ma ZG, Tang QZ. Zhang X, et al. Among authors: xu sc. Cell Death Differ. 2020 Feb;27(2):540-555. doi: 10.1038/s41418-019-0372-z. Epub 2019 Jun 17. Cell Death Differ. 2020. PMID: 31209361 Free PMC article.

2

ATF3: A potential target for cardiac maladaptive remodeling.

Ma ZG, Wei WY, Xu SC, Zhang WB, Dai J, Tang QZ. Ma ZG, et al. Among authors: xu sc. Int J Cardiol. 2016 Jan 1;202:50-1. doi: 10.1016/j.ijcard.2015.08.179. Epub 2015 Aug 28. Int J Cardiol. 2016. PMID: 26386920 No abstract available.

3

Pioglitazone Protected against Cardiac Hypertrophy via Inhibiting AKT/GSK3β and MAPK Signaling Pathways.

Wei WY, Ma ZG, Xu SC, Zhang N, Tang QZ. Wei WY, et al. Among authors: xu sc. PPAR Res. 2016;2016:9174190. doi: 10.1155/2016/9174190. Epub 2016 Mar 27. PPAR Res. 2016. PMID: 27110236 Free PMC article.

4

Asiatic Acid Protects against Cardiac Hypertrophy through Activating AMPKα Signalling Pathway.

Ma ZG, Dai J, Wei WY, Zhang WB, Xu SC, Liao HH, Yang Z, Tang QZ. Ma ZG, et al. Among authors: xu sc. Int J Biol Sci. 2016 May 25;12(7):861-71. doi: 10.7150/ijbs.14213. eCollection 2016. Int J Biol Sci. 2016. PMID: 27313499 Free PMC article.

5

Bezafibrate Attenuates Pressure Overload-Induced Cardiac Hypertrophy and Fibrosis.

Xu SC, Ma ZG, Wei WY, Yuan YP, Tang QZ. Xu SC, et al. PPAR Res. 2017;2017:5789714. doi: 10.1155/2017/5789714. Epub 2017 Jan 3. PPAR Res. 2017. PMID: 28127304 Free PMC article.

6

CTRP3 attenuates cardiac dysfunction, inflammation, oxidative stress and cell death in diabetic cardiomyopathy in rats.

Ma ZG, Yuan YP, Xu SC, Wei WY, Xu CR, Zhang X, Wu QQ, Liao HH, Ni J, Tang QZ. Ma ZG, et al. Among authors: xu cr, xu sc. Diabetologia. 2017 Jun;60(6):1126-1137. doi: 10.1007/s00125-017-4232-4. Epub 2017 Mar 3. Diabetologia. 2017. PMID: 28258411

7

Piperine Attenuates Pathological Cardiac Fibrosis Via PPAR-γ/AKT Pathways.

Ma ZG, Yuan YP, Zhang X, Xu SC, Wang SS, Tang QZ. Ma ZG, et al. Among authors: xu sc. EBioMedicine. 2017 Apr;18:179-187. doi: 10.1016/j.ebiom.2017.03.021. Epub 2017 Mar 14. EBioMedicine. 2017. PMID: 28330809 Free PMC article.

8

CTRP3 protected against doxorubicin-induced cardiac dysfunction, inflammation and cell death via activation of Sirt1.

Yuan YP, Ma ZG, Zhang X, Xu SC, Zeng XF, Yang Z, Deng W, Tang QZ. Yuan YP, et al. Among authors: xu sc. J Mol Cell Cardiol. 2018 Jan;114:38-47. doi: 10.1016/j.yjmcc.2017.10.008. Epub 2017 Oct 20. J Mol Cell Cardiol. 2018. PMID: 29061338

9

Arctiin protects against cardiac hypertrophy through inhibiting MAPKs and AKT signaling pathways.

Li J, Yuan YP, Xu SC, Zhang N, Xu CR, Wan CX, Ren J, Zeng XF, Tang QZ. Li J, et al. Among authors: xu cr, xu sc. J Pharmacol Sci. 2017 Nov;135(3):97-104. doi: 10.1016/j.jphs.2017.05.012. Epub 2017 Aug 10. J Pharmacol Sci. 2017. PMID: 29108833 Free article.

10

Rosmarinic acid attenuates cardiac fibrosis following long-term pressure overload via AMPKα/Smad3 signaling.

Zhang X, Ma ZG, Yuan YP, Xu SC, Wei WY, Song P, Kong CY, Deng W, Tang QZ. Zhang X, et al. Among authors: xu sc. Cell Death Dis. 2018 Jan 24;9(2):102. doi: 10.1038/s41419-017-0123-3. Cell Death Dis. 2018. PMID: 29367637 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

208 results

Search Page

Filters